Guerbet SA logo

Guerbet SA (GBTp)

Market Closed
CBOE CBOE
- Market Cap
- P/E Ratio
- Div Yield
- Volume
0 Eps
Want to track GBTp and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

GBTp is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on XMUN (EUR).

Guerbet SA (GBTp) FAQ

On which exchange is it traded?

Guerbet SA is listed on CBOE.

What is its stock symbol?

The ticker symbol is GBTp.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Guerbet SA ever had a stock split?

No, there has never been a stock split.

Guerbet SA Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Mr. Philippe Bourrinet CEO
CBOE Exchange
- ISIN
France Country
2,653 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Guerbet SA is a pioneering company dedicated to the development and marketing of diagnostic and interventional imaging solutions worldwide. Established in 1926, the company has consistently been at the forefront of the imaging field, offering a wide range of contrast media products, delivery systems, medical devices, and related solutions. Headquartered in Villepinte, France, Guerbet SA is committed to advancing medical imaging technology to improve patient diagnosis and treatment, with a strong emphasis on innovation, particularly in the realms of MRI, CT, and Cath Lab consumables and digital solutions.

Products and Services

Guerbet SA's product lineup is diverse, covering different aspects of medical imaging and treatment. Here are some of their key offerings:

  • Optiray and Xenetix: These are non-ionic, monomeric, and iodinated contrast agents used in various imaging procedures to improve clarity and detail.
  • Telebrix Gastro: A meglumine ioxitalamate solution designed for gastrointestinal imaging.
  • Conray: An iothalamate meglumine injection used for enhancing diagnostic images.
  • Micropaque/Microtrast: A diagnostic imaging interconnected solution, which enhances the visualization of specific body parts during imaging procedures.
  • Dotarem and Artirem: Gadoteric acid-based products acting as MRI contrast agents, facilitating clearer imaging of internal structures.
  • Prefilled Syringes, Injectors, Accessories, and Consumables: For MRI, CT, and Cath Lab procedures, these products ensure efficient delivery of contrast media and seamless imaging processes.
  • Digital Solutions:
    • Contrast&Care: An injection management solution that optimizes the use and tracking of contrast media.
    • Dose&Care: An X-ray dose management solution that helps control and reduce patients' exposure to radiation.
    • icobrain: A cloud-based AI solution that supports the quantification of disease-specific brain structures on MR and CT scans, aiding in the diagnosis and treatment of acute and chronic neurological conditions.
  • Interventional Radiology Products: Including Lipiodol, Vectorio, Patent Blue V, Axessio, and SeQure and DraKon microcatheters for targeted treatment and diagnostic procedures in interventional radiology.
  • Hydra Vision: A digital imaging system designed for use in urological, gastroenterological, and gynecological treatments, as well as for planning and diagnostic procedures.
  • Urology Accessories and Consumables: Specialized tools and products to support urological procedures and treatments.

Contact Information

Address: 15 rue des Vanesses
Phone: 33 1 45 91 50 00